Literature DB >> 10812500

IL-8 producing cells in patients with Behçet's disease.

C Mantas1, H Direskeneli, D Oz, S Yavuz, T Akoglu.   

Abstract

OBJECTIVE: IL-8 is thought to be the principal chemokine responsible for neutrophil activation and tissue infiltration in patients with Behçet's disease (BD). In various studies serum levels of IL-8 were reported to be increased.
METHODS: IL-8 mRNA was purified from both peripheral whole blood samples and separated lymphocytes, granulocytes and monocytes of patients with BD and compared to that from healthy (HC) and disease controls. IL-8 sequences were revealed by PCR amplification using appropriate sequence-specific primers. mRNA levels were determined semi-quantitatively using an image analyser in comparison with beta-actin.
RESULTS: Although the differences did not reach statistical significance, BD patients tended to have higher IL-8 mRNA levels compared to HC in whole blood samples (2.0 +/- 1.4 vs 1.5 +/- 1.2) as well as in their lymphocytes (2.7 +/- 1.6 vs 1.5 +/- 0.9). No differences were observed between BD and HC in monocyte or granulocyte IL-8 mRNA levels.
CONCLUSION: Our results suggest that the cellular source of IL-8 is diverse in BD with a possible major contribution by lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812500

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Elevated serum chemokine levels in Behçet's disease with uveitis.

Authors:  N Bozkurt; H Kazokoglu; S Yavuz; T Bavbek; H Direskeneli
Journal:  Rheumatol Int       Date:  2003-04-24       Impact factor: 2.631

2.  Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation.

Authors:  Simone Schmid; Petra C Kuechler; Markus Britschgi; Urs C Steiner; Nikhil Yawalkar; Alain Limat; Kurt Baltensperger; Lasse Braathen; Werner J Pichler
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.

Authors:  Filiz Türe Özdemir; Emel Ekşioğlu Demiralp; Sibel Z Aydın; Pamir Atagündüz; Tülin Ergun; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2016-12-01

4.  Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.

Authors:  Y Imamura; M S Kurokawa; H Yoshikawa; K Nara; E Takada; C Masuda; S Tsukikawa; S Ozaki; T Matsuda; N Suzuki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

5.  Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease.

Authors:  R H A Mohammed
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

Review 6.  'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

Authors:  Dennis McGonagle; Sibel Zehra Aydin; Ahmet Gül; Alfred Mahr; Haner Direskeneli
Journal:  Nat Rev Rheumatol       Date:  2015-11-03       Impact factor: 20.543

Review 7.  Behçet's disease.

Authors:  Shunsei Hirohata; Hirotoshi Kikuchi
Journal:  Arthritis Res Ther       Date:  2003-04-02       Impact factor: 5.156

8.  Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.

Authors:  Tanya Novak; Mojgan Hamedi; Lesley Ann Bergmeier; Farida Fortune; Eleni Hagi-Pavli
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

9.  Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.

Authors:  Giuseppe Lopalco; Orso Maria Lucherini; Antonio Vitale; Rosaria Talarico; Antonio Lopalco; Mauro Galeazzi; Giovanni Lapadula; Luca Cantarini; Florenzo Iannone
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.